Francesco G. Salituro, Marlborough, MA (US); Albert Jean Robichaud, Boston, MA (US); Gabriel Martinez Botella, Wayland, MA (US); and Boyd L. Harrison, Princeton Junction, NJ (US)
Assigned to Sage Therapeutics, Inc., Cambridge, MA (US)
Filed by Sage Therapeutics, Inc., Cambridge, MA (US)
Filed on Aug. 6, 2021, as Appl. No. 17/396,034.
Application 17/396,034 is a continuation of application No. 15/742,424, granted, now 11,117,924, previously published as PCT/US2016/041175, filed on Jul. 6, 2016.
Claims priority of provisional application 62/332,931, filed on May 6, 2016.
Claims priority of provisional application 62/189,068, filed on Jul. 6, 2015.
Prior Publication US 2022/0048943 A1, Feb. 17, 2022